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Objective: Lipid peroxides and their reactive aldehyde derivatives (LPPs) have been linked to obesity-related pathologies, but whether they have
a causal role has remained unclear. Glutathione peroxidase 4 (GPx4) is a selenoenzyme that selectively neutralizes lipid hydroperoxides, and
human gpx4 gene variants have been associated with obesity and cardiovascular disease in epidemiological studies. This study tested the
hypothesis that LPPs underlie cardio-metabolic derangements in obesity using a high fat, high sucrose (HFHS) diet in gpx4 haploinsufﬁcient mice
(GPx4þ/) and in samples of human myocardium.
Methods: Wild-type (WT) and GPx4þ/ mice were fed either a standard chow (CNTL) or HFHS diet for 24 weeks, with metabolic and car-
diovascular parameters measured throughout. Biochemical and immuno-histological analysis was performed in heart and liver at termination of
study, and mitochondrial function was analyzed in heart. Biochemical analysis was also performed on samples of human atrial myocardium from
a cohort of 103 patients undergoing elective heart surgery.
Results: Following HFHS diet, WT mice displayed moderate increases in 4-hydroxynonenal (HNE)-adducts and carbonyl stress, and a 1.5-fold
increase in GPx4 enzyme in both liver and heart, while gpx4 haploinsufﬁcient (GPx4þ/) mice had marked carbonyl stress in these organs
accompanied by exacerbated glucose intolerance, dyslipidemia, and liver steatosis. Although normotensive, cardiac hypertrophy was evident with
obesity, and cardiac ﬁbrosis more pronounced in obese GPx4þ/mice. Mitochondrial dysfunction manifesting as decreased fat oxidation capacity
and increased reactive oxygen species was also present in obese GPx4þ/ but not WT hearts, along with up-regulation of pro-inﬂammatory and
pro-ﬁbrotic genes. Patients with diabetes and hyperglycemia exhibited signiﬁcantly less GPx4 enzyme and greater HNE-adducts in their hearts,
compared with age-matched non-diabetic patients.
Conclusion: These ﬁndings suggest LPPs are key factors underlying cardio-metabolic derangements that occur with obesity and that GPx4
serves a critical role as an adaptive countermeasure.
 2015 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords Glutathione peroxidase 4; Lipid peroxidation; Obesity; Mitochondria; Inﬂammation; Human heart1. INTRODUCTION
The prevalence of obesity is rapidly spreading throughout the world
with over 28% of adults having a body mass index (BMI) of 25 kg/1Department of Pharmacology & Toxicology, East Carolina University, Greenville, NC,
United States 3Department of Public Health, East Carolina University, Greenville, NC, U
Greenville, NC, United States 5East Carolina Heart Institute, East Carolina University, G
*Corresponding author. Department of Pharmacology & Toxicology, Brody School of Med
United States. E-mail: andersonet@ecu.edu (E.J. Anderson).
Abbreviations: PUFA, polyunsaturated fatty acids; LPPs, lipid peroxidation end products;
control; BMI, body mass index; 4-HNE, 4-hydroxynonenal; ROS, reactive oxygen species
ejection fraction; FS, fractional shortening; Nrf2, nuclear factor (erythroid-derived 2)-lik
iNOS, inducible nitric oxide synthase; RAGE, receptor for advanced glycation end produ
myosin heavy chain; TGF-b1, transforming growth factor beta 1; TGF-b2, transformin
Received March 24, 2015  Revision received April 8, 2015  Accepted April 14, 201
http://dx.doi.org/10.1016/j.molmet.2015.04.001
MOLECULAR METABOLISM 4 (2015) 493e506  2015 The Authors. Published by Elsevier GmbH. This is an o
www.molecularmetabolism.comm2 [1,2]. In addition to the increased risk for type 2 diabetes, a
growing number of studies have reported a high prevalence of car-
diomyopathy in obese patients (w40% by some estimates) [3], with
‘preclinical’ myocardial damage [4] and diastolic dysfunction alreadyUnited States 2Department of Physiology, East Carolina University, Greenville, NC,
nited States 4East Carolina Diabetes and Obesity Institute, East Carolina University,
reenville, NC, United States
icine, East Carolina University, BSOM 6S-11, 600 Moye Blvd., Greenville, NC 27834,
GPx4, glutathione peroxidase 4; HFHS, high fat, high sucrose; WT, wild type; CNTL,
; RNS, reactive nitrogen species; HDL, high-density lipoprotein; TG, triglycerides; EF,
e 2; IL-1b, interleukin-1 beta; IL-6, interleukin-6; TNF-a, tumor necrosis factor-a;
cts; Coll1a1, collagen, type I, alpha; Coll4a1, collagen, type IV, alpha 1; b-MHC, b
g growth factor beta 2
5  Available online 22 April 2015
pen access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 493
Original articleevident in young adult (35 yrs) obese/diabetic patients [5] and even
children [6]. Importantly, these cardiac derangements appear in the
absence of detectable coronary disease or hypertension. Together,
these ﬁndings strongly indicate a need for more careful examination
of potential mechanisms that underlie cardiomyopathy in obese
individuals.
Polyunsaturated fatty acids (PUFAs) are continuously oxidized in vivo
through both enzymatic and non-enzymatic reactions [7,8], forming
lipid peroxidation end products (LPPs) such as isoprostanes, isofurans,
thromboxanes, and a,b-unsaturated aldehydes [9], all of which have
biological effects [10e13]. These aldehydes cause post-translational
modiﬁcations of proteins through Michael addition with lysines and
histidines, and through covalent modiﬁcation of sulfhydryl groups (e.g.,
cysteines) to form carbonyl adducts [14,15]. Due to this high degree of
reactivity, many of these aldehydes have been proposed to be etiologic
agents in disease [7,14,16e21]. 4-hydroxynonenal (HNE) is a a,b-
unsaturated aldehyde derived from n-6 PUFA peroxidation, and HNE
levels increase proportionally with ROS/RNS levels [22]. One recent
report showed that HNE-modiﬁed albumin is signiﬁcantly increased in
the serum of type 2 diabetic patients [23].
Mitochondrial membranes are abundant with unsaturated fatty
acids, which are prone to peroxidation [24e26]. The mitochondrion
is also the primary source of cellular ROS, making it a major
source of LPPs [27]. As a countermeasure, mitochondria contain an
elaborate system of antioxidant and LPP-detoxifying enzymes. One
of these is glutathione peroxidase 4 (GPx4), which resides in the
mitochondrial inner membrane (in addition to nucleus and cytosol)
to speciﬁcally scavenge lipid hydroperoxides [28e30]. GPx4 is one
of a few antioxidant enzymes known to neutralize both simple and
complex lipid hydroperoxides (e.g., Cholesterol hydroperoxide)
[31,32]. It is the only member of the GPx super-family that is
indispensable during development, with embryonic lethality of GPx4
null mice occurring at stage E7.5 [33e35]. In recent genetic and
epidemiological studies, variants of gpx4 that result in diminished
content and/or catalytic activity have been associated with obesity
[36], cardiovascular disease [37,38] and inﬂammation [39,40].
However, no experimental studies to date have explored GPx4 in
the context of obesity or its related pathologies, and this may be a
signiﬁcant oversight given the well-known association between
mitochondrial-derived oxidative stress and metabolic disease
[41,42]. In this study, we tested the hypothesis that LPPs are a
causal factor underlying cardio-metabolic derangements in
obesity by investigating the effect of a long-term high fat, high
sucrose (HFHS) diet in a mouse model of gpx4 haploinsufﬁciency
(GPx4þ/) and in samples of human atrial myocardium obtained
from non-diabetic and diabetic patients undergoing elective heart
surgery.Table 1 e Body composition and metabolic parameters.
Variables WT
CNTL
WT
HFHS
Terminal body weight (g) 34.5  1.3 48.0  2.2*
Fat mass (g) 8.4  1.0 17.7  0.9*
Lean mass (g) 21.6  0.4 26.0  1.2*
Body fat (%) 24.0  2.1 36.9  0.5*
Fasting glucose (mg/dL) 141.3  4.1 168.6  14.2*
Cholesterol (mg/dL) 51.0  8.6 72.8  6.5
Triglycerides (mg/dL) 46.8  6.3 44.0  10.6
HDL cholesterol (mg/dL) 74.9  8.0 96.7  7.2
All values expressed as mean  S.E.M., n ¼ 4e6 per group. * P<0.05 vs. WT-CNTL vs.
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2.1. GPx4 deﬁciency in obesity leads to enhanced lipid
peroxidation and carbonyl stress in liver, exacerbating insulin
resistance and steatosis
To test our hypothesis that LPPs underlie obesity-related pathologies
we used a GPx4-deﬁcient (GPx4þ/) mouse model. GPx4þ/ mice are
phenotypically indistinguishable from WT in the absence of an exog-
enous stressor but more susceptible to damage from radiation and
environmental toxicants [43,44]. The rationale for using this mouse
model was that it mimics the effect of previously identiﬁed gpx4 gene
variants on GPx4 enzyme levels and activity in human cells [36,38,45].
Following HFHS diet no signiﬁcant differences in adiposity or weight
gain were observed between WT and GPx4þ/ mice, although obese
GPx4þ/ mice had substantial dyslipidemia and fasting hyperglycemia
with HFHS diet (Table 1). Whole body energy expenditure, determined
by VO2 and VCO2 using indirect calorimetry, was not different between
WT and GPx4þ/ mice, either with CNTL or HFHS diet (data not
shown). Glucose intolerance was exacerbated in the GPx4þ/ mice
compared with WT (Figure 1A), although serum insulin levels were
increased with HFHS diet to equal extent regardless of genotype
(Figure 1B). GPx4 enzyme levels in liver of WT mice increased
signiﬁcantly as a result of HFHS diet, although GPx4þ/ mice contain
signiﬁcantly less enzyme than WT (Figure 1C and Supplemental
Figure 1A). In parallel with the increase in GPx4, levels of HNE-
adducts in liver increased in WT with HFHS diet but were signiﬁ-
cantly more pronounced in GPx4þ/ mice compared with WT. To
determine whether the increased lipid peroxidation in the GPx4þ/
mice corresponded to a more severe liver pathology following HFHS
diet, liver triglycerides and collagen were measured by oil red O and
picrosirius red staining, respectively. GPx4þ/ mice displayed greater
liver steatosis (Figure 1D) and ﬁbrosis (Figure 1E) than WT mice
following HFHS diet.
2.2. Cardiac structural remodeling and ﬁbrosis are exacerbated by
GPx4 deﬁciency in obesity
Previous studies have shown that HFHS diet-induced obesity causes
signiﬁcant cardiac hypertrophy and left ventricular (LV) diastolic
dysfunction in rodent models [46e48]. Here, HFHS diet caused an
increase in cardiac mass to a similar extent between WT and GPx4þ/
mice (Figure 2A,E). However, compared with WT, GPx4þ/ mice
display signiﬁcantly greater cardiomyocyte diameter (Figure 2E,F) and
ﬁbrosis (Figure 2B,C) following HFHS diet. Obese mice also have
increased levels of serum brain natriuretic peptide (BNP, Figure 2G),
indicative of ventricular wall stress. This evidence of cardiomyopathy
exists in the absence of any changes in LV systolic function (Figure 2H),
blood pressure (Figure 2I) or heart rate (Figure 2J) in the mice followingGPx4þ/-CNTL GPx4þ/
HFHS
p-value
35.8  4.2 48.5  1.2*x <0.0001
10.0  2.9¤ 19.4  0.8*x 0.0001
22.3  1.4¤ 24.9  0.4* 0.004
31.3  3.0* 40.0  0.8*x <0.0001
148.0  3.7 204.8  11.3*¤x 0.007
34.0  8.7 103.5  17.8*x 0.01
55.5  1.5 99.5  11.3*¤x 0.003
53.1  9.4 118.4  14.4*x 0.009
¤ P<0.05 vs. WT-HFHS. x P<0.05 vs. GPX4þ/- CNTL.
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Figure 1: Glycemic control and liver biochemistry/pathology. Shown in A are oral glucose tolerance tests, along with fed-state serum insulin levels B after 24 weeks on the
diet. In C are representative immunoblots of GPx4 and HNE-adducts in liver from 4 individual mice in each group, along with the corresponding b-actin loading control.
Representative images of liver triglycerides stained with oil red O D, and collagen stained with picrosirius red under polarized light E are shown for each group. Images are
representative of 16 image ﬁelds captured per mouse, n ¼ 2e3 mice per treatment group. Data shown as mean  S.E.M., n ¼ 7e8 mice per group. *P < 0.05 vs. CNTL within
genotype, yP < 0.05 vs. WT-HFHS.HFHS diet, indicating that any cardiomyopathy which might be present
in these mice is not due to increased afterload.
Recently, in two independent experimental models of cardiac hyper-
trophy it was observed that GPx4 and Thioredoxin Reductase (TxnRd)
were the only antioxidant seleno-enzymes to increase in the heart,
suggesting that they are critical for cardiac compensatory response to
hypertrophic stimuli [49,50]. A signiﬁcant increase in GPx4 mRNA
(Figure 3A) and enzyme content (Figure 3B and Supplemental
Figure 1B) in myocardium of WT mice with HFHS diet was observed.
Conversely, GPx4þ/ mice had lower levels of mRNA that did not
correspond to any signiﬁcant change in GPx4 enzyme levels following
HFHS diet. Levels of HNE-adducts (Figure 3C) and protein carbonyls
(Figure 3C) do increase moderately in WT hearts with HFHS diet,
although GPx4 deﬁciency leads to a striking increase in this protein
carbonylation with obesity. To determine if GPx4 deﬁciency and
augmented carbonyl stress in obesity triggered a compensatory redox
adaptive response in the heart, expression of a number of antioxidant
genes were examined. GPx4þ/ mice were found to have increased
expression of several antioxidant genes following HFHS diet
(Figure 3D).
2.3. GPx4 deﬁciency causes mitochondrial abnormalities and up-
regulation of cardiac inﬂammation and ﬁbrosis signaling pathways
with obesity
Mitochondrial dysfunction, as characterized by decreased ATP and/or
respiration combined with increased ROS, has been linked to several
obesity-related pathologies, including insulin resistance and cardio-
myopathy, and recent studies have implicated a role for mitochondrial
protein carbonylation in mediating this dysfunction [51e53]. Param-
eters of mitochondrial function in permeabilized LV myoﬁbers were
examined to assess the relationship between GPx4 deﬁciency,
carbonyl stress, and mitochondria in the obese myocardium. GPx4MOLECULAR METABOLISM 4 (2015) 493e506  2015 The Authors. Published by Elsevier GmbH. This is an o
www.molecularmetabolism.comenzyme content was measured in the mitochondrial fraction isolated
from whole hearts. GPx4 increased in cardiac mitochondria of WT mice
with HFHS diet, while total levels of GPx4 were lower and remained
that way following HFHS diet in the GPx4þ/ mice (Figure 4A and
Supplemental Figure 2A).
It was expected that mitochondrial GPx4 deﬁciency would potentially
lead to a greater degree of mitochondrial membrane lipid peroxidation
and reactive aldehyde formation. Here, the amount of mitochondrial
HNE-adducts were greater in GPx4þ/ hearts than WT, and the HFHS
diet increased the relative amount of these adducts in both WT and
GPx4þ/ mice (Figure 4B and Supplemental Figure 2B). These
increased HNE-adducts may have functional consequences since
recent studies have documented that mitochondrial HNE-adducts
correspond to decreased oxidative phosphorylation in diabetic heart
mitochondria [74,75]. Moreover, another report highlights the impor-
tance of mitochondrial fatty acid b-oxidation as a metabolic ‘sink’ for
HNE [72]. In WT hearts, both basal and maximal ADP-stimulated
palmitoyl-L-carnitine supported respiration was markedly increased
following HFHS diet, while these rates were unchanged with HFHS diet
in the GPx4þ/ mice (Figure 4B).
In a previous study we reported that the selenoenzyme thioredoxin
reductase-2 (TxnRd2) increased in rat heart with HFHS diet [54],
corresponding to a decreased rate of mitochondrial H2O2 emission in
the obese rat heart. Other groups have also reported decreased
mitochondrial ROS with obesity/diabetes in mouse [55] and rat models
[56]. Given our previous ﬁndings, combined with the fact that TxnRd2
expression was increased in GPx4þ/ hearts with HFHS diet
(Figure 3E), we sought to ascertain whether a similar adaptation in
redox buffering was occurring in cardiac mitochondria of these mice.
Here, using paired H2O2 emission experiments in the absence and
presence of the TxnRd2 inhibitor auranoﬁn, a dramatic (w4-fold) in-
crease in total H2O2 emission was observed in permeabilizedpen access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 495
Figure 2: Cardiac structural and functional parameters. Panels shown are representative images of whole hearts A, cardiac collagen stained with picosirius red under
polarized light B,C, and Masson’s Trichrome stained cardiac tissue D, from mice within each study group. Shown in E are heart weight/tibia length ratio, cardiomyocyte diameter F,
and serum BNP levels G. Cardiac contractility H, mean arterial pressure I, and heart rate J are shown for each group Images are representative of 16 image ﬁelds captured per
mouse, n ¼ 2e3 mice per treatment group. Data in E-J are shown as mean  S.E.M., n ¼ 6e8 mice per group. *P < 0.05 vs. WT-CNTL, yP < 0.05 vs. WT-HFHS, xP < 0.05 vs.
GPx4þ/--CNTL.
Original articlemyoﬁbers prepared from obese GPx4þ/ mice fed HFHS diet, while a
decrease in this ROS emission was observed in the obese WT mice
following HFHS diet (Figure 4C). Auranoﬁn exposure signiﬁcantly
increased the rate of mitochondrial ROS in the obese WT mice but not
obese GPx4þ/ mice.
Chronic, low-grade inﬂammation in the obese heart is known to cause
proﬁbrotic and hypertrophic signaling. Although it has been difﬁcult to
fully ascertain the exact nature of the relationship between inﬂam-
mation and cardiac remodeling, some investigators have proposed that
activation of the receptor for advanced glycation end products (RAGE)
may play a role. RAGE belongs to a family of pattern recognition re-
ceptors for AGE and has been studied extensively in the context of
diabetes-related pathologies [57,58]. Increased expression of RAGE is
present in the hearts of obese GPx4þ/ mice (Figure 5A), and this is
consistent with the increased carbonyl stress present in these hearts
since reactive aldehydes such as HNE are known to potentiate AGE
formation [59]. Activation of RAGE has been shown to induce chronic
activation of nuclear factor kappa-light-chain-enhancer of activated B
cells (NFkB), which, in turn, activates further inﬂammatory pathways.
Furthermore, there is extensive crosstalk between the RAGE and
Transforming Growth Factor-Beta (TGF-b) family of proteins [60e62].
Notably, the hearts of obese GPx4þ/ mice also displayed greater pro-
inﬂammatory cytokine expression and genes involved in ﬁbrosis and
hypertrophy compared with WT following HFHS diet, while only a
modest increase in a few select genes was observed with HFHS diet in
WT hearts (Figure 5A & B).496 MOLECULAR METABOLISM 4 (2015) 493e506  2015 The Authors. Published by Elsevier GmbH.2.4. Cardiac GPx4 deﬁciency is associated with increased HNE-
adducts and relative risk (RR) for diabetes in humans
Next, we sought to determine whether there is an association between
GPx4 and lipid-derived carbonyl stress in human heart and, also, to
examine whether there is a connection between these parameters and
human metabolic disease. In a small pilot study ofw20 patients, we
previously reported greater levels of HNE-protein adducts in the hearts
of hyperglycemic type 2 diabetic patients, and these increased HNE-
adducts were accompanied by depletion of cardiac glutathione and
increased mitochondrial ROS production [63]. Here, using samples of
atrial myocardium obtained from patients (n ¼ 103) undergoing
elective cardiac surgery (Table 2), we observed that diabetic patients
had signiﬁcantly less cardiac GPx4 than non-diabetic patients
(Figure 6A), and this corresponded with greater levels of HNE-adducts
in the diabetic hearts (Figure 6B). A multivariable regression analysis
was performed on quartiles of cardiac GPx4 and tertiles of HNE-
adducts, and cardiac GPx4 was found to be negatively associated
while HNE-adducts positively associated with RR for diabetes in these
patients (Table 3). To determine if hyperglycemia was associated with
cardiac GPx4 or HNE-adducts in these patients, a multiple linear
regression model was applied, adjusting for sex. No signiﬁcant as-
sociation between cardiac GPx4 or HNE-adduct levels and HbA1c was
observed in these patients (Table 3 and Supplemental Figure 1).
Similar to what was observed with the WT-HFHS mice, cardiac GPx4
content was positively correlated with cardiac HNE-adducts in these
patients (Figure 6C), suggesting that GPx4 is an adaptive response ofThis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 3: Cardiac GPx4, protein carbonylation and redox signaling. Shown here is GPx4 mRNA expression A and protein content B in whole hearts from mice used in this
study. Representative immunoblot of HNE-adducts and hydrazide-labeled protein carbonyls C are shown from 3 individual mice in each group, Expression of redox and phase II
detoxifying genes are shown in D. Data shown in A & D are means  S.E.M, n ¼ 5e7 per group. *P < 0.05 vs. WT-CNTL, ¤ P < 0.05 vs. WT-HFHS, xP < 0.05 vs. GPx4þ/--CNTL.
CAT-Catalase; TrxII- Thioredoxin reductase II; GR- Glutathione Reductase; GPX1- Glutathione Peroxidase1; NQO1- NAD(P)H:quinine oxidoreductase; HO-1- Heme oxygenase-1;
GSTA1-glutathione s-transferase-1.
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Figure 4: Cardiac mitochondrial GPx4 and functional parameters. A representative immunoblot of GPx4 protein A and HNE-adducts B along with corresponding COX IV loading
control are shown of isolated cardiac mitochondria obtained from mice used in this study. In C are maximal ADP-stimulated rates of mitochondrial respiration (JO2) supported by
palmitoyl-L-carnitine in permeabilized cardiac myoﬁbers from these mice. Shown in D are rates of mitochondrial H2O2 emission (mito-JH2O2) in phosphorylating state supported by
palmitoyl-L-carnitine þ 100 mM ADP, in the absence () and presence (þ) of the TxnRd2 inhibitor Auranoﬁn. Data shown in C & D are means  S.E.M, N ¼ 4e6 per group.
*P < 0.05 vs. all other groups for each respiratory state, yP < 0.05 vs. WT-HFHS, xP < 0.05 vs. GPx4þ/--CNTL, #P < 0.05 for Auranoﬁn effect within group.
Original article
498 MOLECULAR METABOLISM 4 (2015) 493e506  2015 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
www.molecularmetabolism.com
Figure 5: Cardiac inﬂammatory and pro-ﬁbrotic/hypertrophic gene expression.
Expression of pro-inﬂammatory A, pro-ﬁbrotic and hypertrophy genes B are shown in
hearts from all four groups of mice in this study. B-MHC- b-Myosin Heavy Chain;
Coll1a1-Collagen 1a1; Coll4a1-Collagen 4a1; TGFb1 and 2 -Transforming Growth
Factorb 1 and 2; IL-b-Interleukin-1 Beta; IL-6 -Interleukin 6; TNF-a-Tumor Necrosis
Factor-alpha; iNOS-Inducible nitric oxide synthase; RAGE- Receptor for Advanced
Glycation End Products. All target genes normalized to 18S ribosome RNA. Data shown
are means  S.E.M, N ¼ 4e6 per group. *P < 0.05 vs. WT-CNTL, ¤ P < 0.05 vs. WT-
HFHS, xP < 0.05 vs. GPx4þ/--CNTL.the tissue to persistent oxidative stress. Interestingly, the ratio of HNE-
adducts/GPx4 was much higher in diabetic than non-diabetic hearts
(Figure 6D), indicating that the GPx4 adaptive response has been over-
whelmed or compromised in these patients.
3. DISCUSSION
Only an increased understanding of the mechanisms underlying
obesity-related pathologies will enable physicians to better manage
diseases associated with this emerging epidemic. Lipid peroxides and
their reactive aldehyde derivatives have been postulated to play a
causal role in obesity-related cardio-metabolic diseases, and emerging
epidemiologic data has reported a link between polymorphisms and
mutations in gpx4 and human diseases, including obesity. Together,
these previous ﬁndings suggest that GPx4 may be an adaptive
component that serves a protective role against the persistent oxidative
stress in obesity. The present study tested this hypothesis in a
translational model of HFHS diet-induced obese GPx4þ/ (i.e. GPx4
deﬁcient) mice, combined with cardiac tissue samples obtained from
patients undergoing elective cardiac surgery. The ﬁndings from this
study demonstrate that GPx4 deﬁciency with diet-induced obesity
leads to signiﬁcant increases in lipid peroxide-derived aldehydes,
corresponding to more severe cardio-metabolic derangements
including glucose intolerance, dyslipidemia, liver steatosis, and cardiac
hypertrophy and ﬁbrosis. Abnormalities in mitochondrial function in
hearts from the obese GPx4þ/ mice implicate a role for the enzyme in
protecting that critical organelle from oxidative damage in obesity.MOLECULAR METABOLISM 4 (2015) 493e506  2015 The Authors. Published by Elsevier GmbH. This is an o
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GPx4þ/ mice was accompanied by up-regulation of genes involved in
cardiac inﬂammation and remodeling, illustrating the importance of
carbonyl stress as a causal factor in these pathways. Lastly, the
relationship between decreased cardiac GPx4 and increased HNE-
adducts and human metabolic disease was conﬁrmed by studying
cardiac tissue samples obtained from non-diabetic and diabetic pa-
tients. Collectively, these observations allow for a proposed model of
GPx4 as a protective adaptation in obesity (as shown in the Graphical
Abstract). Clearly, when lipid peroxidation increases as a result of
persistent oxidative stress in obesity/nutrient overload, GPx4 is upre-
gulated to compensate (Figures 1 and 3). However, over time and
possibly due to underlying genetic causes, GPx4 becomes over-
whelmed in an obese individual and HNE-adducts increase (along with
numerous other LPPs that were not measured in this study). The
consequence of this is increased inﬂammation, mitochondrial
dysfunction (and likely potentiation of mitochondrial ROS), and the
broad cardio-metabolic pathologies that are known to follow (e.g.,
diabetes, cardiomyopathy, liver disease).
These ﬁndings stand in contrast to preceding studies of diet-induced
obesity in antioxidant-deﬁcient models. One recent study of high fat-
fed GPx1-deﬁcient mice (whole body GPx1/) found that systemic
oxidative stress increased with obesity as expected, but these mice
were actually protected from insulin resistance and liver steatosis [98].
In a study using high fat diet in SOD2þ/ mice (also exhibiting greater
oxidative stress), insulin sensitivity was again unchanged with obesity,
although a modest effect on pancreatic b-cell release of insulin was
observed [99]. Another intriguing study used high fat diet in a
glutathione-deﬁcient (Gclm/) mouse model. The authors found that
despite a huge increase in systemic oxidative stress with the diet,
these mice were also protected from increased adiposity, insulin
resistance and steatosis, possibly due to an increase in basal energy
expenditure [100]. Given these recent ﬁndings, the fact that GPx4
haploinsufﬁciency alone can induce such a damaging effect on cardio-
metabolic parameters with HFHS diet implies that lipid peroxides and
their LPP derivatives are a distinctive form of oxidative stress that must
play a very prominent etiological role in obesity-related cardio-meta-
bolic diseases.
Deleterious effects of lipid-derived aldehydes in biological systems
have been well known for many years. For example, nucleophilic
attack of cysteine residues by aldehydes has negative ramiﬁcations on
metabolic pathways in the cell [14,64]. A recent mass spectrometric
analysis of cysteine oxidation status in hearts from mice fed a dia-
betogenic diet for 8 months showed that w40% of total oxidized
cysteines are mitochondrial in origin [65]. Proteomic analysis of
mitochondria from diabetic rat hearts reveals an increased formation of
carbonyl adducts (e.g. HNE, MDA) with complexes of the electron
transport chain and respiratory complexes, and these adducts corre-
spond to a reduction in enzyme activity [18]. Our data suggest that
GPx4 protects against cardiac mitochondrial dysfunction with obesity
as the obese GPx4þ/ mice had very high levels of carbonyl stress in
their hearts (Figure 3), particularly HNE-adducts in the cardiac mito-
chondria (Figure 4B), accompanied by mitochondrial dysfunction, as
compared with obese WT mice. Several studies have shown that GPx4
preserves ATP production and attenuates cytochrome c release in the
mitochondria under oxidative stress [66e68]. Cardiac-speciﬁc over-
expression of mitochondrial GPx4 is protective in models of cardiac
ischemia/reperfusion injury and in a streptozotocin (STZ)-induced
diabetes model [69,70]. GPx4 exists as both short (i.e., mitochondrial-
localized) and long (i.e., cytosolic-localized) isoforms, yet only deletion
of the former is lethal in mice [67]. Thioredoxin Reductase is the onlypen access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 499
Table 2 e Patient clinical and demographic characteristics.
Variables Diabetes
n (%)
No diabetes
n (%)
p-value
Age
Mean  SD 64  9.28 61  11 0.49
Median (IQR) 65 (16) 60 (17)
Sex
Female 7 (14) 1 (2)
Male 42 (85) 53 (97) 0.026
Race
White 41 (83) 47 (86) 0.78
Black 8 (16) 7 (13)
BMI
Mean  SD 31  6.6 30  5.3 0.46
Median (IQR) 30 (7.4) 29 (4.5)
Preoperative medications
b-blockers 34 (69) 41 (75) 0.87
ACEi/ARBs 15 (31) 22 (41) 0.79
Diuretics 21 (43) 20 (37) 0.69
CCBs 10 (20) 13 (24) 0.89
Diabetic medications 43 (87) 2 (4) <0.0001
Insulin 32 (65) 2 (4)
Metformin 15 (31) 0
Sulfonylureas 4 (8) 0
Glitazones 1 (2) 0
GLP-1 agonist 2 (4) 0
DDP-4 inhibitor 3 (6) 0
Statins 41 (83) 46 (84) 0.94
Nitrates 19 (39] 32 (59) 0.65
Heart failure 8 (16) 5 (9) 0.31
LVEF (%) 51.8  3.9 53.6  6.4 0.87
Sample size N ¼ 103 for GPx4, N ¼ 61 for HNE-adduct.
Figure 6: GPx4 content and HNE-adducts in human myocardium. Total GPx4 enzym
diabetic and diabetic patients undergoing elective heart surgery. Shown in C is associati
HNE-adduct to GPx4 enzyme are depicted in D. Each symbol corresponds to one individ
computed using Friedman’s nonparametric test for central tendency, adjusting for sex.
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has both mitochondrial (TxnRd2) and cytosolic (TxnRd1) isoforms [71].
In the present study, increased mitochondrial H2O2 emission was
observed in hearts of lean GPx4þ/ mice following the inhibition of
TxnRd2 with auranoﬁn (Figure 4C), although auranoﬁn did not signif-
icantly affect the rate in the obese GPx4þ/ mice (which was already
much greater than all other groups). This suggests that mitochondrial
lipid peroxide-scavenging with GPx4 and the thioredoxin redox couple
are both important adaptive responses of cardiac mitochondria in
obesity-related cardiac hypertrophy and that TxnRd2 cannot appro-
priately compensate for GPx4 deﬁciency within cardiac mitochondria if
animals are obese.
A recent study showed that fatty acid b-oxidation is a novel HNE
clearance pathway in heart [72]. Considering the diminished rates of
maximal palmitoyl carnitine-supported respiration observed in the
obese GPx4þ/ hearts, it is plausible that the elevated carbonyl stress
observed in the hearts of these mice is a result of both increased
mitochondrial ROS production (which initiates more lipid peroxidation)
as well as a disruption of aldehyde detoxiﬁcation pathways. The
decreased GPx4 and correspondingly increased HNE-adducts seen
here in myocardium of diabetic patients support our previous obser-
vations of decreased palmitoyl-L-carnitine supported respiration and
increased mitochondrial ROS in diabetic human hearts [42,73]. A link
between mitochondrial HNE-adduct formation and decreased oxidative
phosphorylation in diabetic heart mitochondria has recently been made
[74,75], and our ﬁndings suggest that GPx4 deﬁciency may underlie
these oxidative modiﬁcations. High variability in dietary fat may also be
a contributor to the greater levels of cardiac HNE-adducts in the dia-
betic patients, as it has been reported that diets consisting of high fat
mixed with carbohydrate, or high fat alone, can lead to drasticallye content A and HNE-adducts B are shown in atrial myocardium obtained from non-
on between HNE-adducts and GPx4 enzyme in these heart samples, and the ratio of
ual patient (N ¼ 103, see Table 2 for demographics and clinical variables). P-value
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 3 e Multivariable analysis of GPx4 and HNE-adducts in human heart.
GPx4 content (ug/ml)
Diabetes
n (%)
No diabetes
n (%)
RR (95% CI)a
Mean  SD 6.2  4.2 8.7  5.9 P ¼ 0.034b
Median (IQR) 6.0 (5.2) 6.7 (6.6)
Q1 (3.9) 17 (35) 9 (17) 1.0 Referent
Q2 (>3.9e6.3) 10 (20) 15 (28) 0.65 (0.37e1.1)
Q3 (>6.3e9.4) 13 (27) 13 (24) 0.74 (0.47e1.2)
Q4 (>9.4) 9 (18) 17 (31) 0.58 (0.31e1.1)
Ptrend ¼ 0.063c
HNE content (mM)
Mean  SD 18  8.3 14  9.8 P ¼ 0.028b
Median (IQR) 16 (11) 11 (12)
T1 (9.0) 3 (10) 21 (47) 1.0 Referent
T2 (>9.0e17) 14 (47) 11 (24) 4.2 (1.4e13)
T3 (>17) 13 (43) 13 (29) 3.9 (1.2e12)
Ptrend ¼ 0.050c
a Relative Risk (RR) and 95% Conﬁdence Interval (CI), adjusted for sex.
b P-value computed using Friedman’s Nonparametric test for central tendency,
adjusting for sex.
c P-value computed using the likelihood ratio trend test, adjusting for sex.different outcomes in HNE accumulation in oxidative tissues [101].
Other studies directed at examining the role that alternative aldehyde-
producing (e.g., monoamine oxidase) and detoxifying enzymes (e.g.,
aldehyde dehydrogenases) may have in pathologies of obese/diabetic
hearts may also be useful [64]. In addition, an improved understanding
of the regulation of selenocysteine status may serve as a major clue to
uncovering the mechanisms that govern the progression to mal-
adaptive remodeling in hearts of patients with metabolic disease.
Epidemiological studies of Keshan’s disease, a cardiomyopathy
endemic to regions of China, conﬁrm that the heart is highly sus-
ceptible to injury resulting from disturbances to selenocysteine en-
zymes. Cardiomyopathy in Keshan’s disease manifests as acute
cardiac ﬁbrosis and mitochondrial dysfunction [76], a phenotype that is
strikingly similar to the GPx4þ/ mice in the present study.
Aside from measurements of liver steatosis and serum lipids, our study
did not explore the potential contribution of altered lipid metabolism
that might exist in these mice. Lipotoxicity is a consistent feature of
cardio-metabolic disease in both humans and animal models of obesity
[77e82] and therefore may contribute to the severe liver and cardiac
pathology observed in the obese GPx4þ/ mice. The obese GPx4þ/
mice do not possess signiﬁcantly greater adiposity than obese WT, as
determined by % body fat. However, we cannot exclude that there may
have been differences in adipose distribution between groups. It is also
known that GPx4 directly modulates the lipoxygenase and cyclo-
oxygenase II enzyme systems, and, when viewed in this context, the
increased cardiac inﬂammation present in obese GPx4þ/ mice sup-
ports a potential role for prostaglandins and other oxidized lipids in
mediating the severe metabolic pathologies in this model. Thus, we
cannot exclude the contribution of these mediators in the obese
GPx4þ/ mice. Other studies have documented that proteolysis and
autophagy become compromised with carbonyl stress, and the
diminished activity of these cellular processes may also explain the
more severe phenotype observed in the obese GPx4þ/ hearts [83,84].
None of these alternative pathways were explored in the present study.
It is anticipated that these ﬁndings will serve to lay a foundation for
future mechanistic studies directed at understanding how LPPs
contribute to obesity-related pathologies and the adaptive role of GPx4.
Considering that the most severe effects observed in the obese GPx4þ/MOLECULAR METABOLISM 4 (2015) 493e506  2015 The Authors. Published by Elsevier GmbH. This is an o
www.molecularmetabolism.com mice were evident in oxidative tissues (i.e., liver, heart, muscle), it
will be very important in future studies to identify the cell- and tissue-
speciﬁc role of GPx4 in mediating lipid peroxidation and carbonyl stress
with obesity. Furthermore, our ﬁndings have clinical implications as
they suggest that patients exhibiting decreased GPx4 expression and
activity might be predisposed to obesity-related cardio-metabolic
diseases. Indeed, clinical studies and human cell models have shown
that GPx4 expression and activity vary widely in response to envi-
ronmental and nutritional cues [38,45,85e88]. Finally, although our
understanding of the role of lipid-derived aldehydes and carbonyl
stress in the etiology of obesity-related diseases is in its infancy, it is
important to recognize that compounds that scavenge HNE and other
lipid-derived aldehydes speciﬁcally, such as histidine-containing di-
peptides, may be very useful in this regard [89,90,102] and have
experienced some success in pre-clinical testing and even clinical
trials [91e93]. Thus, further research into novel therapeutics targeting
carbonyl stress will be important for mitigating the numerous cardio-
metabolic diseases that accompany this rising epidemic of obesity.
4. METHODS
4.1. Mouse model and study design
Animal care and experimental procedures were performed with
approval from the Institutional Animal Care and Use Committee of East
Carolina University and were in compliance with the National Institutes
of Health’s Guide for Care and Use of Laboratory Animals. C57BL6/J
female mice (Jackson Laboratory) were crossed to male GPx4þ/mice
and pups were genotyped by polymerase chain reaction (PCR) using
primers described in [43]. At 8e12 weeks, WT and GPx4þ/ male and
female age-matched littermates (n ¼ 6) were randomly assigned to
groups and individually housed. Mice were fed either control (CNTL-
TD110367) or high fat high sucrose (HFHS-TD110365) diet from
Harlan-Teklad Laboratories (Madison, WI) ad libidum for 25 weeks.
The composition of this diet was a special formulation consisting of
mixed saturated and n-6 PUFA (44.6% kcal/g fat), with high sucrose
(34% kcal/g) content [54]. Mice were housed at controlled temperature
and a 12hr light/dark cycle was maintained. At the end of the diet
period, all live animal metabolic and echocardiographic measurements
were made 1e2 weeks prior to tissue collection to allow for a ‘wash-
out period’ to minimize artifact attributable to additional stress that
may have been introduced by these procedures.
4.2. Patient enrollment and myocardial tissue collection
The Institutional Review Board of the Brody School of Medicine at East
Carolina University approved all aspects of this study. Adult patients
undergoing primary, non-emergent elective coronary artery bypass graft
(CABG) or CABG/valve surgery between January 2011 and December
2014 were enrolled for this study. Demographic and clinical variables
for these patients, including preoperative cardiovascular and metabolic
drugs, are listed in Table 2 according to diabetes status. Those having
prior cardiac surgery, history of arrhythmia, or severely enlarged atria
(>4.0 cm) were excluded from the study. Atrial appendage biopsies
were obtained from each patient as previously described [94], directly
prior to institution of cardiopulmonary bypass. Myocardium was
dissected from the endocardial side of the biopsy, rinsed brieﬂy and
frozen in liquid N2. All samples were rapidly processed this way to
minimize protein and mRNA degradation across patients.
4.3. Metabolic parameters
Body weight of the mice was recorded on a weekly basis throughout
HFHS diet. Body composition was analyzed by nuclear-MRI (EchoMRIpen access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 501
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test (dose-0.5 g/kg) was performed following aw4 h fast in week 22
of the HFHS diet period. Glucose levels were measured using a
standard glucometer (OneTouch UltraMini, LifeScan, Milpitas, CA) in
blood collected from a tail nick. Serum cholesterol, high-density li-
poprotein (HDL), and triglycerides (TG) were analyzed using UniCel DxC
600 (Beckman Coulter, Indianapolis, IN).
4.4. Assessment of cardiovascular function
At end of the diet intervention, blood pressure was determined by non-
invasive tail-cuff plethysmography (SC1000, Hattaras Instruments,
Cary, NC). Mice were acclimated to the procedure for 3 days, and the
average of blood pressure readings made over 3 consecutive days was
recorded. A single recording was an average of 10 measurements after
5 acclimatization cycles, with duration no longer than 10 min, at
approximately the same time every day. Also at this time, high-
resolution echocardiography was performed on fully conscious mice
using a 30 MHz transducer (Vevo 2100, VisualSonics, Toronto, ON) to
assess cardiac function and structural parameters in vivo. Parasternal
long- and short-axis views were captured in M-mode and recordings
analyzed using system software.
4.5. Liver and cardiac histology
Mice were anesthetized with isoﬂurane. Hearts (n ¼ 2/group) were
stopped with KCl, ﬁxed in Zinc Fixative then embedded in parafﬁn.
Next, they were cut cross-sectionally, stained in Hematoxylin and eosin
or picosirus red (collagen), then viewed under polarized light. Livers
from these animals were ﬁxed, embedded and stained in a similar
fashion, with the exception that oil red O was used for liver tri-
glycerides. Images of each heart were captured at 20X. The car-
diomyocyte diameter of 8e10 myocytes from 5 captured images per
animal was analyzed using Image J (http://imagej.nih.gov/ij/) by an
individual blinded to the treatment group.
4.6. Preparation of permeabilized cardiac myoﬁbers and
mitochondrial function measurements
All procedures for these measurements have been described in detail
by our group previously [42,54,73,95]. The mice were anesthetized
with isoﬂurane and rapidly euthanized by pneumothorax. Blood was
collected for serum analysis via cardiac puncture. Whole hearts were
dissected, weighed, and a small portion of the left ventricle (LV) was
cut for preparation of permeabilized myoﬁbers (w30 mg) and placed
in Buffer X containing (in mM): 7.23 K2EGTA, 2.77 CaK2EGTA, 20
Imidazole, 20 Taurine, 5.7 ATP, 14.3 Phosphocreatine, 6.56 MgCl2-
6H2O and 50 MES (pH 7.1, 295 mOsm). Of the remaining LV/septum,
one portion was used for standard mitochondrial isolation, and another
was snap frozen in liquid N2 and stored at 80 C for further
biochemical analysis. Following permeabilization in 50 mg/ml saponin
for 30 min, ﬁbers were transferred to Buffer Z containing (in mM):
110 K-MES, 35 KCl, 1 EGTA, 5 K2HPO2, 3 MgCl2-6H2O, and 5 mg/ml
BSA (pH 7.4, 295 mOsm) and remained in Buffer Z with 20uM
Blebbstatin on a rotator at 4 C until analysis (<1.5 h). Fibers were
then transferred to an Oroboros O2K (Oroboros Instruments, Innsbruck,
Austria) where respiration was recorded in Buffer Z þ 20uM Bleb-
bistatin, 20 mM Creatine at 30 C. Respiration (JO2) measurements
were performed following addition of 125uM palmitoyl-
carnitine þ 1 mM malate followed by 4 mM ADP. H2O2 emission was
measured using a spectroﬂuorometer (Photon Technology In-
struments, Birmingham, NJ) in Buffer Z þ 20uM Blebbistatin, 10 mM
Amplex Red, 1 U/ml horseradish peroxidase, 25 U/ml superoxide dis-
mutase. For H2O2 measurements, respiratory substrates used were502 MOLECULAR METABOLISM 4 (2015) 493e506  2015 The Authors. Published by Elsevier GmbH.125 palmitoyl-carnitine, 2 mM Malate þ100 mM ADP, 5 mM glucose
and 1 U/ml hexokinase (i.e., phosphorylating state) followed by
sequential addition of 5 mM glutamate then 5 mM succinate. Once
mitochondrial experiments completed, ﬁbers were collected, rinsed in
ddH2O to remove excess salts, and lyophilized (Labconco, Kansas City,
MO). Fibers were then weighted on a microbalance (Mettler Toledo,
Denver, CO) and mitochondrial JO2 (oxygen consumption rate) and
JH2O2 (peroxide emission rate) were normalized to dry weight.
4.7. Real-time qPCR of gene expression
Cardiac samples (w10 mg) were homogenized in glass grinders
(Kimble Chase, Vineland, NJ) then subjected to Proteinase K digestion.
All materials used in RNA extraction were provided in RNeasy Fibrous
Tissue Mini Kit (Qiagen Inc, Valencia, CA cat# 74704). Reverse Tran-
scription was performed using the iScript  cDNA Kit (Biorad Labo-
ratories, Hercules, CA cat# 170e8891). The SsoAdvanced SYBER 
Green reaction cocktail was used in the ampliﬁcation and detection of
DNA in RT-PCR. All protocols were performed according to product
speciﬁcations unless otherwise stated. Cycle threshold (C(t)) values
were converted to relative gene expression levels using the 2-DDC(t)
method and normalized to the level of 18S ribosomal RNA. Data are
reported as fold-change in gene expression (arbitrary units)  S.E.M.
relative to WT-CNTL mice (n ¼ 4e5 per group). The sequences and
references for the primers used in qRT-PCR are listed in Supplemental
Table 1.
4.8. Mitochondria isolation
The technique applied has been modiﬁed from methods previously
described [96,97]. Brieﬂy, w100 mg of cardiac tissue was excised
and added to a petri dish with ice. The tissue was minced for 4e5 min,
until it could pass through a pipette, and subjected to a brief (2 min)
trypsin incubation. The mixture was transferred to a 50 mL conical
tube and allowed to settle. The supernatant was removed and dis-
carded. The remaining mixture was resuspended in 3 mL of Mito-
chondria Isolation Medium (MIM) (300 mM Sucrose, 10 mM Na-
HEPES, 0.2 mM EDTA) with BSA, then transferred to a pre-chilled
Dounce homogenizer and slowly homogenized for a total of w10e
12 counts. The homogenate was then subjected to a series of differ-
ential centrifugation steps. The fractions of isolated mitochondria ob-
tained (mixed subsarcolemmal and intermyoﬁbrillar) were
resuspended in a small volume of MIM þ BSA and frozen at 80 for
biochemical analysis.
4.9. Immunoblot and enzyme-linked immunosorbent assay (ELISA)
Cardiac tissue was homogenized in TEET Buffer (10 mM Tris, 1 mM
EDTA, 1 mM EGTAþ 0.5% Triton X-100), then loaded on 4e20% pre-
cast polyacrylamide SDS gel (Biorad, Hercules, CA) under reducing
conditions. Protein was transferred to PVDF membranes (Millipore,
Bellerica, CA) and incubated with primary antibodies for GPx4 and a-
tubulin (Abcam, Cambridge, UK), COX IV and b-actin (Cell Signaling
Technology, Danvers MA), and HNE-adduct (Percipio Biosciences).
Membranes were incubated using infrared ﬂuorophore-conjugated
secondary antibodies (LiCor Biosciences, Lincoln, NE), scanned using
Odyssey Clx Infrared Imaging System (Li-Cor) and analyzed by
densitometry using Image J (NIH). The absolute quantities of GPx4 and
HNE-modiﬁed protein adducts in human cardiac tissue was deter-
mined by a quantitative ELISA approach developed in our lab, as
described previously [54]. Fixed concentrations of HNE-adducts were
made by incubating 4-hydroxynonenal (Cayman Chemical, Ann Arbor,
MI) with BSA. A standard curve of both recombinant GPx4 (AbFrontier,
Seoul, Korea) and HNE-modiﬁed BSA were then incubated onThis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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immunolon-coated 96-well assay plate (Fisher Scientiﬁc) along with
diluted cardiac protein. Samples were incubated overnight at 4 C, and
subsequently washed with PBSþ0.05% Tween-20 and blocked for 2 h
with BSA or NB4025 (NOF America, White Plains, NY) at 37 C.
Samples were then incubated with primary antibodies for GPx4 and
HNE adduct for 2 h at 37 C. Samples were washed with PBSþ0.05%
Tween-20 and incubated with HRP-conjugated secondary antibody for
2 h at 27 C. Following this incubation, samples were washed as
before and incubated with Amplex Red (10 mM). Concentrations of
GPx4 and HNE-adducts in the samples were determined by ﬁtting to
the standard curve within each plate and normalized to total protein
concentration.
4.10. Hydrazide labeling of carbonyl-modiﬁed proteins
Hydrazide Cy5.5 dye (GE Healthcare Bio-Sciences, Pittsburgh, PA) was
diluted in dimethyl sulfoxide (DMSO) at a stock concentration 1 mg/ml.
Tissue was homogenized under an anaerobic chamber (Coy Laboratory
Products, Grass Lake, MI) in 10 mM sodium phosphate buffer, con-
taining 0.1% Triton X-100, and de-gassed using dry vacuum pump
(Welch No. 25228e01, Monroe, LA). Dye was added to half of the
homogenate (1:10). The samples were left under anaerobic conditions
for 2 h and incubated overnight on orbital shaker at 4 C. The other
aliquot of tissue homogenate was used to quantify protein content.
Portions of the labeled cardiac tissue homogenate were subjected to
SDS-PAGE on 10% SDS polyacrylamide gel. The gels were scanned
using Odyssey Clx Infrared Imaging System (Li-Cor) and Cy5.5-labeled
proteins were analyzed by densitometry using Image J (NIH).
4.11. Statistical analysis
All animal data are presented as mean  SEM. Statistical analysis on
mouse model variables were performed with GraphPad Prism
(GraphPad Prism, La Jolla, Ca.). One way ANOVA was performed on
continuous variables followed by NewmaneKeuls post test, with
a < 0.05 considered statistically signiﬁcant. In the human data
analysis, categorical variables are presented as frequency and per-
centage and continuous variables were presented as mean standard
deviation, mediation, median and interquartile range. Fisher exact and
Chi (c2) procedures were used to compute statistical signiﬁcance of
group comparisons for categorical variables. Deuchler-Wilcoxon was
used for continuous variables. Biochemical variables were divided into
quartiles (GPx4) or tertiles (HNE) and analyzed using a robust Poisson
regression model (with relative risk as the measure of association).
Missing values for all clinical and biochemical variable were imputed
using the iterative expectation-maximization (EM) algorithm as
described in a recent study [94]. Variables that were statistically sig-
niﬁcant in the univariable analysis were included into the multivariable
analysis. P-value was computed using Friedman’s Nonparametric test
for central tendency while adjusting for age. Ptrend was computed using
likelihood ratio trend test, adjusting for age and sex. Statistical sig-
niﬁcance was deﬁned as P < 0.05. SAS Version 9.3 was used for all
analyses of human biochemical and clinical variables.
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